Article Type
Audio
Changed
Mon, 01/14/2019 - 14:17
Display Headline
Who benefits most from aspirin to prevent CVD and colorectal cancer?
Author(s)
Doug Campos-Outcalt, MD, MPA

Author and Disclosure Information

Dr. Campos-Outcalt is an assistant editor of The Journal of Family Practice and the medical director for Mercy Care Plan in Phoenix, Ariz.

Issue
The Journal of Family Practice - 65(5)
Publications
The Journal of Family Practice
MDedge Family Medicine
Topics
Cardiology
Oncology
Page Number
audio
Legacy Keywords
Doug Campos-Outcalt, MD, MPA, CVD, cardiovascular disease, colorectal cancer, oncology, aspirin, pharmacology
Author(s)
Doug Campos-Outcalt, MD, MPA
Author(s)
Doug Campos-Outcalt, MD, MPA
Author and Disclosure Information

Dr. Campos-Outcalt is an assistant editor of The Journal of Family Practice and the medical director for Mercy Care Plan in Phoenix, Ariz.

Author and Disclosure Information

Dr. Campos-Outcalt is an assistant editor of The Journal of Family Practice and the medical director for Mercy Care Plan in Phoenix, Ariz.

Related Articles
Time to revise your aspirin prescribing?
Colorectal cancer screening: New USPSTF draft recommendations

Issue
The Journal of Family Practice - 65(5)
Issue
The Journal of Family Practice - 65(5)
Page Number
audio
Page Number
audio
Publications
The Journal of Family Practice
MDedge Family Medicine
Publications
The Journal of Family Practice
MDedge Family Medicine
Topics
Cardiology
Oncology
Article Type
Audio
Display Headline
Who benefits most from aspirin to prevent CVD and colorectal cancer?
Display Headline
Who benefits most from aspirin to prevent CVD and colorectal cancer?
Legacy Keywords
Doug Campos-Outcalt, MD, MPA, CVD, cardiovascular disease, colorectal cancer, oncology, aspirin, pharmacology
Legacy Keywords
Doug Campos-Outcalt, MD, MPA, CVD, cardiovascular disease, colorectal cancer, oncology, aspirin, pharmacology
Disallow All Ads
Alternative CME
Use ProPublica
Teaser Media